Concerned about the possible increased risk of heart attacks and death recently associated with Avandia, users may find useful information in two reports which compare Avandia with Actos and other diabetes medications. One report indicates that Actos may not carry the same heart attack risk as… Read More
According to the Associated Press, the number of reported heart problems associated with Avandia has jumped significantly since a study published May 21 in the New England Journal of Medicine demonstrated an increased risk of heart attacks and death associated with the diabetes drug. With knowledge… Read More
The American College of Radiology (ACR) issued an update to their 2004 guidelines on MRI safety, called the ACR Guidance Document for Safe MR Practices. A section of the document is devoted to discussing the risk of Nephrogenic Systemic Fibrosis (NSF), also known as Nephrogenic Fibrosing… Read More
The FDA reported today that a new warning will be added to Rocephin for Injection, an antibiotic manufactured by Roche Holding AG. When combined with calcium or calcium-containing products, the antibiotic could cause a fatal reaction in the lungs and kidneys of newborn babies, especially those… Read More
The association between AMO Complete MoisturePlus contact lens solution and Acanthamoeba keratitis is very strong according to investigators who are continuing to review reports. The recalled contact lens solution appears to be the direct cause of injury for hundreds of people nationwide. >>INFORMATION: Complete MoisturePlus Lawsuits… Read More
Yesterday the FDA released a new black box warning for the asthma drug Xolair (omalizumab), which will provide a stronger label regarding the risk of anaphylaxis, a serious and potentially fatal allergic reaction. They also announced that a new Medication Guide will be provided to those… Read More
A study published last week provides further evidence directly linking bisphosphonates to an increased risk of jaw bone decay, known as osteonecrosis of the jaw. The study involved intravenous bisphosphonates which are used to treat bone cancer, osteoporosis and other conditions. Although the study did not address the… Read More
Yesterday the FDA issued a public health advisory regarding a risk of death associated with the use of Coly-Mycin M and generic forms of colistimethate when used in a premixed form for inhalation with a nebulizer. Although colistimethate is only approved by the FDA for intravenous… Read More
Yesterday Advanced Medical Optics, Inc. (AMO) revised their financial guidance to reflect the impact of the Complete MoisturePlus recall. The popular contact lens solution was removed from the market after CDC officials linked it to an increased risk of Acanthamoeba Keratitis, a rare and possibly blinding eye… Read More
Yesterday at the annual meeting of the American Diabetes Association in Chicago, the debate about heart risks associated with Avandia was a main topic. Concerns have been widespread among diabetes patients and doctors about an increased risk of heart attacks and heart related death since a… Read More
